Form 4: Abacus Global CFO Vesting 283,333 Shares
Insider Transaction Report
Abacus Global Management's CFO, William Hugh McCauley JR, reported the vesting of 283,333 common shares on July 3, 2025, as part of his Restricted Stock Unit grants.
Summary
- William Hugh McCauley JR, Chief Financial Officer of Abacus Global Management, Inc. (ABL), reported a change in beneficial ownership.
- On July 3, 2025, McCauley acquired 283,333 shares of common stock through the vesting of Restricted Stock Units (RSUs).
- The shares vested at a price of $0, indicating they were part of an equity compensation plan.
- Following this transaction, McCauley directly beneficially owns 795,000 shares of Abacus Global Management common stock.
- The vesting of 283,333 shares on July 3, 2025, includes shares from the October 27, 2023 RSU grant, which was modified on March 27, 2025, to vest one-third of the grant on July 3 of 2024, 2025, and 2026.
- Other outstanding time-based RSUs include 166,667 from the October 27, 2023 grant, 8,000 from a February 13, 2024 grant, 125,000 from a December 13, 2024 grant, and 125,000 from an April 2, 2025 grant, all with staggered vesting schedules.
Sentiment
Score: 7
Explanation: The filing reports the vesting of a significant number of shares for a key executive, which is a positive event for the individual's compensation and aligns their interests with shareholders. It reflects the execution of pre-established compensation plans.
Positives
- CFO McCauley acquired a significant number of shares (283,333) through RSU vesting, increasing his direct beneficial ownership to 795,000 shares.
- The vesting event aligns the executive's interests with those of shareholders, as his compensation is tied to the company's equity performance.
- The modification of the October 27, 2023 RSU grant terms provides a clear and structured vesting schedule for a portion of the executive's equity compensation.
Future Outlook
This Form 4 filing primarily reports an insider transaction and does not contain forward-looking statements or guidance regarding the company's operational or financial performance.
Industry Context
This Form 4 filing details an individual insider transaction related to executive compensation and does not provide information relevant to broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: The vesting of shares represents a routine, expected form of executive compensation, which may result in minor dilution but also aligns the executive's long-term interests with shareholder value.
- Employees: This filing reflects standard executive compensation practices, which can influence overall compensation strategies within the company.
Next Steps
- Future vesting of remaining RSUs from the October 27, 2023 grant on July 3, 2026.
- Future vesting of RSUs from the February 13, 2024 grant on February 13 of 2025, 2026, and 2027.
- Future vesting of RSUs from the December 13, 2024 grant on December 13 of 2025, 2026, and 2027.
- Future vesting of RSUs from the April 2, 2025 grant on March 27 of 2026, 2027, and 2028.
Key Dates
| Date | Description |
|---|---|
| October 27, 2023 | Original grant date for certain Restricted Stock Units (RSUs). |
| February 13, 2024 | Grant date for 8,000 time-based RSUs. |
| December 13, 2024 | Grant date for 125,000 time-based RSUs. |
| March 27, 2025 | Date of modification for the October 27, 2023 RSU grant terms. |
| April 2, 2025 | Grant date for 125,000 time-based RSUs. |
| July 3, 2024 | Scheduled vesting date for one-third of the October 27, 2023 RSU grant. |
| February 13, 2025 | Scheduled vesting date for one-third of the February 13, 2024 RSU grant. |
| July 3, 2025 | Vesting date for 283,333 shares of common stock, including one-third of the October 27, 2023 RSU grant. |
| December 13, 2025 | Scheduled vesting date for one-third of the December 13, 2024 RSU grant. |
| March 27, 2026 | Scheduled vesting date for one-third of the April 2, 2025 RSU grant. |
| February 13, 2026 | Scheduled vesting date for one-third of the February 13, 2024 RSU grant. |
| July 3, 2026 | Scheduled vesting date for one-third of the October 27, 2023 RSU grant. |
| December 13, 2026 | Scheduled vesting date for one-third of the December 13, 2024 RSU grant. |
| February 13, 2027 | Scheduled vesting date for one-third of the February 13, 2024 RSU grant. |
| March 27, 2027 | Scheduled vesting date for one-third of the April 2, 2025 RSU grant. |
| December 13, 2027 | Scheduled vesting date for one-third of the December 13, 2024 RSU grant. |
| March 27, 2028 | Scheduled vesting date for one-third of the April 2, 2025 RSU grant. |
| September 17, 2025 | Signature date of the reporting person. |
Recommendation
holdThis Form 4 reports a routine, pre-scheduled vesting of Restricted Stock Units for a key executive. While it increases insider ownership, it does not provide new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment thesis. It primarily reflects the execution of an existing compensation plan.
Keywords
Abacus Global Management, ABL, William McCauley, CFO, Form 4, SEC filing, stock vesting, RSU, common stock, beneficial ownership, equity compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.